Exact Mass: 729.6035933999999

Exact Mass Matches: 729.6035933999999

Found 500 metabolites which its exact mass value is equals to given mass value 729.6035933999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(15:0/P-18:1(11Z))

trimethyl[2-({2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-3-(pentadecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C41H80NO7P (729.5672099999999)


PC(15:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/P-18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(15:0/P-18:1(9Z))

trimethyl[2-({2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-(pentadecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C41H80NO7P (729.5672099999999)


PC(15:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/P-18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(15:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/P-18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(18:0/P-18:1(11Z))

(2-aminoethoxy)[(2R)-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(18:0/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/P-18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(18:0/P-18:1(9Z))

(2-aminoethoxy)[(2R)-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(18:0/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/P-18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(18:1(11Z)/P-18:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-octadec-1-en-1-yloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(18:1(11Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/P-18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(18:1(9Z)/P-18:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-octadec-1-en-1-yloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(18:1(9Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/P-18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(20:1(11Z)/P-16:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-hexadec-1-en-1-yloxy]-3-[(11Z)-icos-11-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(20:1(11Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-16:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

CerP(d18:1/24:0)

[(e,2S,3R)-3-Hydroxy-2-(tetracosanoylamino)octadec-4-enyl] dihydrogen phosphate

C42H84NO6P (729.6035933999999)


CerP(d18:1/24:0) is a ceramide 1-phosphate belonging to the sphingolipid class of molecules. Ceramides are amides of fatty acids with long-chain di- or trihydroxy bases, the commonest in animals being sphingosine and in plants phytosphingosine. The acyl group of ceramides is generally a long-chain saturated or monounsaturated fatty acid. The most frequent fatty acids found in animal ceramides are 18:0, 24:0 and 24:1(n-9). Ceramide 1-phosphates are produced by phosphorylation of ceramide by a specific ceramide kinase. Ceramide-1-phosphate was shown to be a specific and potent inducer of arachidonic acid and prostanoid synthesis in cells through the translocation and activation of the cytoplasmic phospholipase A2. [HMDB] CerP(d18:1/24:0) is a ceramide 1-phosphate belonging to the sphingolipid class of molecules. Ceramides are amides of fatty acids with long-chain di- or trihydroxy bases, the commonest in animals being sphingosine and in plants phytosphingosine. The acyl group of ceramides is generally a long-chain saturated or monounsaturated fatty acid. The most frequent fatty acids found in animal ceramides are 18:0, 24:0 and 24:1(n-9). Ceramide 1-phosphates are produced by phosphorylation of ceramide by a specific ceramide kinase. Ceramide-1-phosphate was shown to be a specific and potent inducer of arachidonic acid and prostanoid synthesis in cells through the translocation and activation of the cytoplasmic phospholipase A2.

   

PC(P-18:1(11Z)/15:0)

trimethyl(2-{[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C41H80NO7P (729.5672099999999)


PC(P-18:1(11Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/15:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(P-18:1(9Z)/15:0)

trimethyl[2-({3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-(pentadecanoyloxy)propyl phosphonato}oxy)ethyl]azanium

C41H80NO7P (729.5672099999999)


PC(P-18:1(9Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/15:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/15:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-16:0/20:1(11Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(11Z)-icos-11-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(P-16:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(P-18:0/18:1(11Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(P-18:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(dm18:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(dm18:0/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/18:1(9Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(P-18:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(11Z)/18:0)

(2-aminoethoxy)[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(P-18:1(11Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(P-18:1(9Z)/18:0)

(2-aminoethoxy)[(2R)-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


PE(P-18:1(9Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

Phosphatidylethanolamine alkenyl 18:0-18:1

Phosphatidylethanolamine alkenyl 18:0-18:1

C41H80NO7P (729.5672099999999)


   

Phosphatidylethanolamine alkyl 18:0-18:2

Phosphatidylethanolamine alkyl 18:0-18:2

C41H80NO7P (729.5672099999999)


   
   

(2-aminoethoxy)[3-[octadec-1-en-1-yloxy]-2-[octadec-9-enoyloxy]propoxy]phosphinic acid

(2-aminoethoxy)[3-[octadec-1-en-1-yloxy]-2-[octadec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO7P (729.5672099999999)


   

C24 CerP

N-(tetracosanoyl)-sphing-4-enine-1-phosphate

C42H84NO6P (729.6035933999999)


   

C18DH GlcCer

N-(octadecanoyl)-1-beta-glucosyl-sphinganine

C42H83NO8 (729.6118358)


   

PE(P-18:0/18:1)

1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

Lecithin

1-(1-Enyl-vaccenoyl)-2-pentadecanoyl-sn-glycero-3-phosphocholine

C41H80NO7P (729.5672099999999)


   

PE(36:1)

1-(1-Enyl-palmitoyl)-2-eicosenoyl-sn-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

PC(O-16:0/17:2(9Z,12Z))

1-hexadecyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C41H80NO7P (729.5672099999999)


   

PC(P-16:0/17:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C41H80NO7P (729.5672099999999)


   

PC(P-18:0/15:1(9Z))

1-(1Z-octadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C41H80NO7P (729.5672099999999)


   

PE(O-16:0/20:2(11Z,14Z))

1-hexadecyl-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

PE(O-18:0/18:2(9Z,12Z))

1-octadecyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

PE(P-20:0/16:1(9Z))

1-(1Z-eicosenyl)-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

PC O-33:2

1-(1Z-octadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C41H80NO7P (729.5672099999999)


   

PE O-36:2

1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine

C41H80NO7P (729.5672099999999)


   

tetraheptylammonium tetraphenylborate

tetraheptylammonium tetraphenylborate

C52H80BN (729.6383470000001)


   

N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]octadecanamide

N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]octadecanamide

C42H83NO8 (729.6118358)


   

1-O-[2-(Trimethylaminio)ethoxyphosphonyl]-N-oleoylsphingosine

1-O-[2-(Trimethylaminio)ethoxyphosphonyl]-N-oleoylsphingosine

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-(octadecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-(octadecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-azaniumylethyl (2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(1Z)-octadec-1-en-1-yloxy]propyl phosphate

2-azaniumylethyl (2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(1Z)-octadec-1-en-1-yloxy]propyl phosphate

C41H80NO7P (729.5672099999999)


   

beta-D-glucopyranosyl-N-(octadecanoyl)sphinganine

beta-D-glucopyranosyl-N-(octadecanoyl)sphinganine

C42H83NO8 (729.6118358)


   

beta-D-galactosyl-(1<->1)-N-octadecanoylsphinganine

beta-D-galactosyl-(1<->1)-N-octadecanoylsphinganine

C42H83NO8 (729.6118358)


A beta-D-galactosyl-(1<->1)-N-acylsphinganine in which the acyl group is specified as octadecanoyl.

   

N-(2-hydroxyoctadecanoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

N-(2-hydroxyoctadecanoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

C41H79NO9 (729.5754524)


   

1-(1Z-octadecenyl)-sn-glycero-3-phospho-(N-oleoyl)ethanolamine

1-(1Z-octadecenyl)-sn-glycero-3-phospho-(N-oleoyl)ethanolamine

C41H80NO7P (729.5672099999999)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

C41H80NO7P (729.5672099999999)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 26:0;2O/10:0

HexCer 26:0;2O/10:0

C42H83NO8 (729.6118358)


   

HexCer 10:0;2O/26:0

HexCer 10:0;2O/26:0

C42H83NO8 (729.6118358)


   

HexCer 13:0;2O/23:0

HexCer 13:0;2O/23:0

C42H83NO8 (729.6118358)


   

HexCer 25:0;2O/11:0

HexCer 25:0;2O/11:0

C42H83NO8 (729.6118358)


   

HexCer 12:0;2O/24:0

HexCer 12:0;2O/24:0

C42H83NO8 (729.6118358)


   

HexCer 11:0;2O/25:0

HexCer 11:0;2O/25:0

C42H83NO8 (729.6118358)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (25Z,28Z)-hexatriaconta-25,28-dienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (25Z,28Z)-hexatriaconta-25,28-dienoate

C41H80NO7P (729.5672099999999)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

C49H79NO3 (729.6059624)


   

HexCer 18:1;2O/17:0;O

HexCer 18:1;2O/17:0;O

C41H79NO9 (729.5754524)


   

HexCer 16:0;2O/19:1;O

HexCer 16:0;2O/19:1;O

C41H79NO9 (729.5754524)


   

HexCer 22:0;2O/13:1;O

HexCer 22:0;2O/13:1;O

C41H79NO9 (729.5754524)


   

[3-nonoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

HexCer 22:1;2O/13:0;O

HexCer 22:1;2O/13:0;O

C41H79NO9 (729.5754524)


   

HexCer 17:0;2O/18:1;O

HexCer 17:0;2O/18:1;O

C41H79NO9 (729.5754524)


   

HexCer 19:1;2O/16:0;O

HexCer 19:1;2O/16:0;O

C41H79NO9 (729.5754524)


   

HexCer 20:1;2O/15:0;O

HexCer 20:1;2O/15:0;O

C41H79NO9 (729.5754524)


   

HexCer 19:0;2O/16:1;O

HexCer 19:0;2O/16:1;O

C41H79NO9 (729.5754524)


   

HexCer 20:0;2O/15:1;O

HexCer 20:0;2O/15:1;O

C41H79NO9 (729.5754524)


   

HexCer 21:0;2O/14:1;O

HexCer 21:0;2O/14:1;O

C41H79NO9 (729.5754524)


   

HexCer 21:1;2O/14:0;O

HexCer 21:1;2O/14:0;O

C41H79NO9 (729.5754524)


   

HexCer 17:1;2O/18:0;O

HexCer 17:1;2O/18:0;O

C41H79NO9 (729.5754524)


   

HexCer 18:0;2O/17:1;O

HexCer 18:0;2O/17:1;O

C41H79NO9 (729.5754524)


   

HexCer 16:1;2O/19:0;O

HexCer 16:1;2O/19:0;O

C41H79NO9 (729.5754524)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

C49H79NO3 (729.6059624)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C49H79NO3 (729.6059624)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxynonan-2-yl)tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxynonan-2-yl)tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

C49H79NO3 (729.6059624)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

C49H79NO3 (729.6059624)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C49H79NO3 (729.6059624)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide

C49H79NO3 (729.6059624)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide

C49H79NO3 (729.6059624)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

C49H79NO3 (729.6059624)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxytricosa-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxytricosa-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

C49H79NO3 (729.6059624)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide

C49H79NO3 (729.6059624)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

C49H79NO3 (729.6059624)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide

C49H79NO3 (729.6059624)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C49H79NO3 (729.6059624)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

C49H79NO3 (729.6059624)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxytridecan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxytridecan-2-yl)hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C49H79NO3 (729.6059624)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxyundecan-2-yl)octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxyundecan-2-yl)octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

C49H79NO3 (729.6059624)


   

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)tricos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]nonadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]nonadecane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)henicos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]octadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]octadecane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]hexadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]hexadecane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)hexacos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]hexacosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] octanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] octanoate

C41H80NO7P (729.5672099999999)


   

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]tricosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]tetracosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]tetracosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]icosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)hexadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)hexadec-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydocosanoylamino)icos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)heptadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)heptadec-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)octadec-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]docosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]heptadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]heptadecane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)tetracos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)pentacos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C41H80NO7P (729.5672099999999)


   

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]henicosane-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyicosanoylamino)docos-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytricosanoylamino)nonadec-4-ene-1-sulfonic acid

C42H83NO6S (729.5940777999999)


   

[2-nonanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-nonanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(17Z,20Z)-octacosa-17,20-dienoxy]-2-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(17Z,20Z)-octacosa-17,20-dienoxy]-2-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-heptanoyloxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptanoyloxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] dodecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] dodecanoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] heptadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] heptadecanoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C41H80NO7P (729.5672099999999)


   
   

3-Hydroxy-2-(octadecanoylamino)pentacosane-1-sulfonic acid

3-Hydroxy-2-(octadecanoylamino)pentacosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] pentadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] pentadecanoate

C41H80NO7P (729.5672099999999)


   

2-(Docosanoylamino)-3-hydroxyhenicosane-1-sulfonic acid

2-(Docosanoylamino)-3-hydroxyhenicosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   
   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C41H80NO7P (729.5672099999999)


   
   
   

3-Hydroxy-2-(icosanoylamino)tricosane-1-sulfonic acid

3-Hydroxy-2-(icosanoylamino)tricosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] tetradecanoate

C41H80NO7P (729.5672099999999)


   

3-Hydroxy-2-(tricosanoylamino)icosane-1-sulfonic acid

3-Hydroxy-2-(tricosanoylamino)icosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C41H80NO7P (729.5672099999999)


   
   

2-(Hexacosanoylamino)-3-hydroxyheptadecane-1-sulfonic acid

2-(Hexacosanoylamino)-3-hydroxyheptadecane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

2-(Heptadecanoylamino)-3-hydroxyhexacosane-1-sulfonic acid

2-(Heptadecanoylamino)-3-hydroxyhexacosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C41H80NO7P (729.5672099999999)


   
   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C41H80NO7P (729.5672099999999)


   

3-Hydroxy-2-(nonadecanoylamino)tetracosane-1-sulfonic acid

3-Hydroxy-2-(nonadecanoylamino)tetracosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] nonadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] nonadecanoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate

C41H80NO7P (729.5672099999999)


   

2-(Henicosanoylamino)-3-hydroxydocosane-1-sulfonic acid

2-(Henicosanoylamino)-3-hydroxydocosane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] decanoate

C41H80NO7P (729.5672099999999)


   

3-Hydroxy-2-(pentacosanoylamino)octadecane-1-sulfonic acid

3-Hydroxy-2-(pentacosanoylamino)octadecane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] hexadecanoate

C41H80NO7P (729.5672099999999)


   

3-Hydroxy-2-(tetracosanoylamino)nonadecane-1-sulfonic acid

3-Hydroxy-2-(tetracosanoylamino)nonadecane-1-sulfonic acid

C43H87NO5S (729.6304611999999)


   
   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C41H80NO7P (729.5672099999999)


   

[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-heptadecoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-dodecoxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecoxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(Z)-icos-11-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-icos-11-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-dodecanoyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-dodecanoyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

2-[4-(12-hydroxy-10,13-dimethyl-3-nonadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

2-[4-(12-hydroxy-10,13-dimethyl-3-nonadecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid

C45H79NO6 (729.5907073999999)


   

Cer 14:0;2O/18:4;(3OH)(FA 14:0)

Cer 14:0;2O/18:4;(3OH)(FA 14:0)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/14:1;(3OH)(FA 16:3)

Cer 16:0;2O/14:1;(3OH)(FA 16:3)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/15:0;(3OH)(FA 16:4)

Cer 15:0;2O/15:0;(3OH)(FA 16:4)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/18:3;(3OH)(FA 14:1)

Cer 14:0;2O/18:3;(3OH)(FA 14:1)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/18:4;(3OH)(FA 12:0)

Cer 16:0;2O/18:4;(3OH)(FA 12:0)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/17:3;(3OH)(FA 14:1)

Cer 15:0;2O/17:3;(3OH)(FA 14:1)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/19:4;(3OH)(FA 12:0)

Cer 15:0;2O/19:4;(3OH)(FA 12:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/20:4;(3OH)(FA 12:0)

Cer 14:0;2O/20:4;(3OH)(FA 12:0)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/14:1;(3OH)(FA 17:3)

Cer 15:0;2O/14:1;(3OH)(FA 17:3)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/14:1;(3OH)(FA 18:3)

Cer 14:0;2O/14:1;(3OH)(FA 18:3)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/19:3;(3OH)(FA 13:1)

Cer 14:0;2O/19:3;(3OH)(FA 13:1)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/16:2;(3OH)(FA 16:2)

Cer 14:0;2O/16:2;(3OH)(FA 16:2)

C46H83NO5 (729.6270907999999)


   

Cer 18:0;2O/12:0;(3OH)(FA 16:4)

Cer 18:0;2O/12:0;(3OH)(FA 16:4)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/16:0;(3OH)(FA 16:4)

Cer 14:0;2O/16:0;(3OH)(FA 16:4)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/14:0;(3OH)(FA 18:4)

Cer 14:0;2O/14:0;(3OH)(FA 18:4)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/17:3;(3OH)(FA 15:1)

Cer 14:0;2O/17:3;(3OH)(FA 15:1)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/15:1;(3OH)(FA 16:3)

Cer 15:0;2O/15:1;(3OH)(FA 16:3)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/16:3;(3OH)(FA 15:1)

Cer 15:0;2O/16:3;(3OH)(FA 15:1)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/16:1;(3OH)(FA 16:3)

Cer 14:0;2O/16:1;(3OH)(FA 16:3)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/14:0;(3OH)(FA 16:4)

Cer 16:0;2O/14:0;(3OH)(FA 16:4)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/12:0;(3OH)(FA 18:4)

Cer 16:0;2O/12:0;(3OH)(FA 18:4)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/13:1;(3OH)(FA 17:3)

Cer 16:0;2O/13:1;(3OH)(FA 17:3)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/12:0;(3OH)(FA 19:4)

Cer 15:0;2O/12:0;(3OH)(FA 19:4)

C46H83NO5 (729.6270907999999)


   

Cer 17:0;2O/16:4;(3OH)(FA 13:0)

Cer 17:0;2O/16:4;(3OH)(FA 13:0)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/13:0;(3OH)(FA 18:4)

Cer 15:0;2O/13:0;(3OH)(FA 18:4)

C46H83NO5 (729.6270907999999)


   

Cer 17:0;2O/13:0;(3OH)(FA 16:4)

Cer 17:0;2O/13:0;(3OH)(FA 16:4)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/19:4;(3OH)(FA 13:0)

Cer 14:0;2O/19:4;(3OH)(FA 13:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/13:1;(3OH)(FA 19:3)

Cer 14:0;2O/13:1;(3OH)(FA 19:3)

C46H83NO5 (729.6270907999999)


   

Cer 18:0;2O/16:4;(3OH)(FA 12:0)

Cer 18:0;2O/16:4;(3OH)(FA 12:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/13:0;(3OH)(FA 19:4)

Cer 14:0;2O/13:0;(3OH)(FA 19:4)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/16:4;(3OH)(FA 15:0)

Cer 15:0;2O/16:4;(3OH)(FA 15:0)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/18:3;(3OH)(FA 13:1)

Cer 15:0;2O/18:3;(3OH)(FA 13:1)

C46H83NO5 (729.6270907999999)


   

Cer 17:0;2O/16:3;(3OH)(FA 13:1)

Cer 17:0;2O/16:3;(3OH)(FA 13:1)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/16:4;(3OH)(FA 14:0)

Cer 16:0;2O/16:4;(3OH)(FA 14:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/16:4;(3OH)(FA 16:0)

Cer 14:0;2O/16:4;(3OH)(FA 16:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/16:3;(3OH)(FA 16:1)

Cer 14:0;2O/16:3;(3OH)(FA 16:1)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/17:3;(3OH)(FA 13:1)

Cer 16:0;2O/17:3;(3OH)(FA 13:1)

C46H83NO5 (729.6270907999999)


   

Cer 16:0;2O/16:3;(3OH)(FA 14:1)

Cer 16:0;2O/16:3;(3OH)(FA 14:1)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/18:4;(3OH)(FA 13:0)

Cer 15:0;2O/18:4;(3OH)(FA 13:0)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/15:1;(3OH)(FA 17:3)

Cer 14:0;2O/15:1;(3OH)(FA 17:3)

C46H83NO5 (729.6270907999999)


   

Cer 17:0;2O/13:1;(3OH)(FA 16:3)

Cer 17:0;2O/13:1;(3OH)(FA 16:3)

C46H83NO5 (729.6270907999999)


   

Cer 15:0;2O/13:1;(3OH)(FA 18:3)

Cer 15:0;2O/13:1;(3OH)(FA 18:3)

C46H83NO5 (729.6270907999999)


   

Cer 14:0;2O/12:0;(3OH)(FA 20:4)

Cer 14:0;2O/12:0;(3OH)(FA 20:4)

C46H83NO5 (729.6270907999999)


   
   

HexCer 14:0;2O/22:0

HexCer 14:0;2O/22:0

C42H83NO8 (729.6118358)


   

HexCer 15:0;2O/21:0

HexCer 15:0;2O/21:0

C42H83NO8 (729.6118358)


   

HexCer 16:0;2O/20:0

HexCer 16:0;2O/20:0

C42H83NO8 (729.6118358)


   

HexCer 17:0;2O/19:0

HexCer 17:0;2O/19:0

C42H83NO8 (729.6118358)


   

HexCer 19:0;2O/17:0

HexCer 19:0;2O/17:0

C42H83NO8 (729.6118358)


   

HexCer 20:0;2O/16:0

HexCer 20:0;2O/16:0

C42H83NO8 (729.6118358)


   

HexCer 21:0;2O/15:0

HexCer 21:0;2O/15:0

C42H83NO8 (729.6118358)


   

HexCer 22:0;2O/14:0

HexCer 22:0;2O/14:0

C42H83NO8 (729.6118358)


   

HexCer 24:0;2O/12:0

HexCer 24:0;2O/12:0

C42H83NO8 (729.6118358)


   

HexCer 23:0;2O/13:0

HexCer 23:0;2O/13:0

C42H83NO8 (729.6118358)


   

N-(hexacosanoyl)-4E-hexadecasphingenine-1-phosphate

N-(hexacosanoyl)-4E-hexadecasphingenine-1-phosphate

C42H84NO6P (729.6035933999999)


   
   
   
   
   
   
   
   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate

C41H80NO7P (729.5672099999999)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C41H80NO7P (729.5672099999999)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] icosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] icosanoate

C41H80NO7P (729.5672099999999)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C41H80NO7P (729.5672099999999)


   

[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO7P (729.5672099999999)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-(tetradecanoyl)-1-beta-glucosyl-docosasphinganine

N-(tetradecanoyl)-1-beta-glucosyl-docosasphinganine

C42H83NO8 (729.6118358)


   

N-(pentadecanoyl)-1-beta-glucosyl-heneicosasphinganine

N-(pentadecanoyl)-1-beta-glucosyl-heneicosasphinganine

C42H83NO8 (729.6118358)


   

N-(hexadecanoyl)-1-beta-glucosyl-eicosasphinganine

N-(hexadecanoyl)-1-beta-glucosyl-eicosasphinganine

C42H83NO8 (729.6118358)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]icosanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]icosanamide

C42H83NO8 (729.6118358)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]octadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]octadecanamide

C42H83NO8 (729.6118358)


   

2-[hydroxy-[(2R,3S,4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R,3S,4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]octadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]octadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(2S,3R,4E,6E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E,2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxytetradec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxytetradec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(2S,3R,4E,8E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]henicosanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]henicosanamide

C42H83NO8 (729.6118358)


   

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(2S,3R,4E,6E)-2-(docosanoylamino)-3-hydroxytetradeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-(docosanoylamino)-3-hydroxytetradeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]hexadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]hexadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadecan-2-yl]heptadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadecan-2-yl]heptadecanamide

C42H83NO8 (729.6118358)


   

2-[[(E,2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyhexadecyl] dihydrogen phosphate

[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyhexadecyl] dihydrogen phosphate

C42H84NO6P (729.6035933999999)


   

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]nonadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]nonadecanamide

C42H83NO8 (729.6118358)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]docosanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]docosanamide

C42H83NO8 (729.6118358)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]octadecyl] dihydrogen phosphate

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]octadecyl] dihydrogen phosphate

C42H84NO6P (729.6035933999999)


   

2-[[(2S,3R,4E,8E)-2-(docosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-(docosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxytetracosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(dodecanoylamino)-3-hydroxytetracosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(icosanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)docosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octadecanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(henicosanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptadecanoylamino)-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tridecanoylamino)tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(docosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(docosanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetracos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetracos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-tris(trideuteriomethyl)azanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-tris(trideuteriomethyl)azanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxydotriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxydotriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxynonacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxynonacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)tritriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)tritriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)octacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)octacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(decanoylamino)-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-15,15,16,16,17,17,18,18,18-nonadeuteriooctadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-15,15,16,16,17,17,18,18,18-nonadeuteriooctadec-9-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetracosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tetracosanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxytriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxytriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tricosanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(tricosanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]dodecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]dodecoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)heptacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)hentriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)hentriaconta-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(4E,8E)-2-acetamido-3-hydroxytetratriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-acetamido-3-hydroxytetratriaconta-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[[2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(undecanoylamino)pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C41H82N2O6P+ (729.5910182)


   
   

N-tetracosanoylsphingosine 1-phosphate

N-tetracosanoylsphingosine 1-phosphate

C42H84NO6P (729.6035933999999)


A ceramide 1-phosphate that is N-tetracosanoyl derivative of sphingosine.

   

beta-D-glucosyl-(1<->1)-N-octadecanoylsphinganine

beta-D-glucosyl-(1<->1)-N-octadecanoylsphinganine

C42H83NO8 (729.6118358)


A beta-D-glucosyl-(1<->1)-N-acylsphinganine in which the acyl group specified is octadecanoyl.

   

beta-D-glucosyl-N-(octadecanoyl)sphinganine

beta-D-glucosyl-N-(octadecanoyl)sphinganine

C42H83NO8 (729.6118358)


A sphinganine derivative having a beta-D-glucosyl group at the 1-position and an octadecanoyl group attached to the nitrogen.

   

Hex1Cer(35:1)

Hex1Cer(t17:0_18:1)

C41H79NO9 (729.5754524)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(36:0)

Hex1Cer(d20:0_16:0)

C42H83NO8 (729.6118358)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GalCer 14:0;O2/22:0

GalCer 14:0;O2/22:0

C42H83NO8 (729.6118358)


   

GalCer 14:1;O2/21:0;O

GalCer 14:1;O2/21:0;O

C41H79NO9 (729.5754524)


   

GalCer 15:0;O2/20:1;O

GalCer 15:0;O2/20:1;O

C41H79NO9 (729.5754524)


   

GalCer 15:0;O2/21:0

GalCer 15:0;O2/21:0

C42H83NO8 (729.6118358)


   

GalCer 15:0;O3/20:1

GalCer 15:0;O3/20:1

C41H79NO9 (729.5754524)


   

GalCer 15:1;O2/20:0;O

GalCer 15:1;O2/20:0;O

C41H79NO9 (729.5754524)


   

GalCer 16:0;O2/20:0

GalCer 16:0;O2/20:0

C42H83NO8 (729.6118358)


   

GalCer 16:1;O2/19:0;O

GalCer 16:1;O2/19:0;O

C41H79NO9 (729.5754524)


   

GalCer 17:0;O2/18:1;O

GalCer 17:0;O2/18:1;O

C41H79NO9 (729.5754524)


   

GalCer 17:0;O2/19:0

GalCer 17:0;O2/19:0

C42H83NO8 (729.6118358)


   

GalCer 17:0;O3/18:1

GalCer 17:0;O3/18:1

C41H79NO9 (729.5754524)


   

GalCer 17:1;O2/18:0;O

GalCer 17:1;O2/18:0;O

C41H79NO9 (729.5754524)


   

GalCer 18:0;O2/18:0

GalCer 18:0;O2/18:0

C42H83NO8 (729.6118358)


   

GalCer 18:0;O3/17:1

GalCer 18:0;O3/17:1

C41H79NO9 (729.5754524)


   

GalCer 18:1;O2/17:0;O

GalCer 18:1;O2/17:0;O

C41H79NO9 (729.5754524)


   

GalCer 19:0;O2/17:0

GalCer 19:0;O2/17:0

C42H83NO8 (729.6118358)


   

GalCer 19:0;O3/16:1

GalCer 19:0;O3/16:1

C41H79NO9 (729.5754524)


   

GalCer 19:1;O2/16:0;O

GalCer 19:1;O2/16:0;O

C41H79NO9 (729.5754524)


   

GalCer 20:0;O2/16:0

GalCer 20:0;O2/16:0

C42H83NO8 (729.6118358)


   

GalCer 20:0;O3/15:1

GalCer 20:0;O3/15:1

C41H79NO9 (729.5754524)


   

GalCer 20:1;O2/15:0;O

GalCer 20:1;O2/15:0;O

C41H79NO9 (729.5754524)


   

GalCer 21:0;O2/15:0

GalCer 21:0;O2/15:0

C42H83NO8 (729.6118358)


   

GalCer 21:0;O3/14:1

GalCer 21:0;O3/14:1

C41H79NO9 (729.5754524)


   

GalCer 21:1;O2/14:0;O

GalCer 21:1;O2/14:0;O

C41H79NO9 (729.5754524)


   

GalCer 22:0;O2/14:0

GalCer 22:0;O2/14:0

C42H83NO8 (729.6118358)


   

GalCer 22:1;O2/13:0;O

GalCer 22:1;O2/13:0;O

C41H79NO9 (729.5754524)


   
   
   
   

GlcCer 14:0;O2/22:0

GlcCer 14:0;O2/22:0

C42H83NO8 (729.6118358)


   

GlcCer 14:1;O2/21:0;O

GlcCer 14:1;O2/21:0;O

C41H79NO9 (729.5754524)


   

GlcCer 15:0;O2/20:1;O

GlcCer 15:0;O2/20:1;O

C41H79NO9 (729.5754524)


   

GlcCer 15:0;O2/21:0

GlcCer 15:0;O2/21:0

C42H83NO8 (729.6118358)


   

GlcCer 15:0;O3/20:1

GlcCer 15:0;O3/20:1

C41H79NO9 (729.5754524)


   

GlcCer 15:1;O2/20:0;O

GlcCer 15:1;O2/20:0;O

C41H79NO9 (729.5754524)


   

GlcCer 16:0;O2/20:0

GlcCer 16:0;O2/20:0

C42H83NO8 (729.6118358)


   

GlcCer 16:1;O2/19:0;O

GlcCer 16:1;O2/19:0;O

C41H79NO9 (729.5754524)


   

GlcCer 17:0;O2/18:1;O

GlcCer 17:0;O2/18:1;O

C41H79NO9 (729.5754524)


   

GlcCer 17:0;O2/19:0

GlcCer 17:0;O2/19:0

C42H83NO8 (729.6118358)


   

GlcCer 17:0;O3/18:1

GlcCer 17:0;O3/18:1

C41H79NO9 (729.5754524)


   

GlcCer 17:1;O2/18:0;O

GlcCer 17:1;O2/18:0;O

C41H79NO9 (729.5754524)


   

GlcCer 18:0;O2/18:0

GlcCer 18:0;O2/18:0

C42H83NO8 (729.6118358)


   

GlcCer 18:0;O3/17:1

GlcCer 18:0;O3/17:1

C41H79NO9 (729.5754524)


   

GlcCer 18:1;O2/17:0;O

GlcCer 18:1;O2/17:0;O

C41H79NO9 (729.5754524)


   

GlcCer 19:0;O2/17:0

GlcCer 19:0;O2/17:0

C42H83NO8 (729.6118358)


   

GlcCer 19:0;O3/16:1

GlcCer 19:0;O3/16:1

C41H79NO9 (729.5754524)


   

GlcCer 19:1;O2/16:0;O

GlcCer 19:1;O2/16:0;O

C41H79NO9 (729.5754524)


   

GlcCer 20:0;O2/16:0

GlcCer 20:0;O2/16:0

C42H83NO8 (729.6118358)


   

GlcCer 20:0;O3/15:1

GlcCer 20:0;O3/15:1

C41H79NO9 (729.5754524)


   

GlcCer 20:1;O2/15:0;O

GlcCer 20:1;O2/15:0;O

C41H79NO9 (729.5754524)


   

GlcCer 21:0;O2/15:0

GlcCer 21:0;O2/15:0

C42H83NO8 (729.6118358)


   

GlcCer 21:0;O3/14:1

GlcCer 21:0;O3/14:1

C41H79NO9 (729.5754524)


   

GlcCer 21:1;O2/14:0;O

GlcCer 21:1;O2/14:0;O

C41H79NO9 (729.5754524)


   

GlcCer 22:0;O2/14:0

GlcCer 22:0;O2/14:0

C42H83NO8 (729.6118358)


   

GlcCer 22:1;O2/13:0;O

GlcCer 22:1;O2/13:0;O

C41H79NO9 (729.5754524)


   
   
   
   

HexCer 14:0;O2/22:0

HexCer 14:0;O2/22:0

C42H83NO8 (729.6118358)


   

HexCer 14:1;O2/21:0;2OH

HexCer 14:1;O2/21:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 14:1;O2/21:0;3OH

HexCer 14:1;O2/21:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 14:1;O2/21:0;O

HexCer 14:1;O2/21:0;O

C41H79NO9 (729.5754524)


   

HexCer 15:0;O2/20:1;2OH

HexCer 15:0;O2/20:1;2OH

C41H79NO9 (729.5754524)


   

HexCer 15:0;O2/20:1;3OH

HexCer 15:0;O2/20:1;3OH

C41H79NO9 (729.5754524)


   

HexCer 15:0;O2/20:1;O

HexCer 15:0;O2/20:1;O

C41H79NO9 (729.5754524)


   

HexCer 15:0;O2/21:0

HexCer 15:0;O2/21:0

C42H83NO8 (729.6118358)


   

HexCer 15:0;O3/20:1

HexCer 15:0;O3/20:1

C41H79NO9 (729.5754524)


   

HexCer 15:1;O2/20:0;2OH

HexCer 15:1;O2/20:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 15:1;O2/20:0;3OH

HexCer 15:1;O2/20:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 15:1;O2/20:0;O

HexCer 15:1;O2/20:0;O

C41H79NO9 (729.5754524)


   

HexCer 16:0;O2/20:0

HexCer 16:0;O2/20:0

C42H83NO8 (729.6118358)


   

HexCer 16:1;O2/19:0;2OH

HexCer 16:1;O2/19:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 16:1;O2/19:0;3OH

HexCer 16:1;O2/19:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 16:1;O2/19:0;O

HexCer 16:1;O2/19:0;O

C41H79NO9 (729.5754524)


   

HexCer 17:0;O2/18:1;2OH

HexCer 17:0;O2/18:1;2OH

C41H79NO9 (729.5754524)


   

HexCer 17:0;O2/18:1;3OH

HexCer 17:0;O2/18:1;3OH

C41H79NO9 (729.5754524)


   

HexCer 17:0;O2/18:1;O

HexCer 17:0;O2/18:1;O

C41H79NO9 (729.5754524)


   

HexCer 17:0;O2/19:0

HexCer 17:0;O2/19:0

C42H83NO8 (729.6118358)


   

HexCer 17:0;O3/18:1

HexCer 17:0;O3/18:1

C41H79NO9 (729.5754524)


   

HexCer 17:1;O2/18:0;2OH

HexCer 17:1;O2/18:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 17:1;O2/18:0;3OH

HexCer 17:1;O2/18:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 17:1;O2/18:0;O

HexCer 17:1;O2/18:0;O

C41H79NO9 (729.5754524)


   

HexCer 18:0;O2/18:0

HexCer 18:0;O2/18:0

C42H83NO8 (729.6118358)


   

HexCer 18:0;O3/17:1

HexCer 18:0;O3/17:1

C41H79NO9 (729.5754524)


   

HexCer 18:1;O2/17:0;2OH

HexCer 18:1;O2/17:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 18:1;O2/17:0;3OH

HexCer 18:1;O2/17:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 18:1;O2/17:0;O

HexCer 18:1;O2/17:0;O

C41H79NO9 (729.5754524)


   

HexCer 19:0;O2/17:0

HexCer 19:0;O2/17:0

C42H83NO8 (729.6118358)


   

HexCer 19:0;O3/16:1

HexCer 19:0;O3/16:1

C41H79NO9 (729.5754524)


   

HexCer 19:1;O2/16:0;2OH

HexCer 19:1;O2/16:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 19:1;O2/16:0;3OH

HexCer 19:1;O2/16:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 19:1;O2/16:0;O

HexCer 19:1;O2/16:0;O

C41H79NO9 (729.5754524)


   

HexCer 20:0;O2/16:0

HexCer 20:0;O2/16:0

C42H83NO8 (729.6118358)


   

HexCer 20:0;O3/15:1

HexCer 20:0;O3/15:1

C41H79NO9 (729.5754524)


   

HexCer 20:1;O2/15:0;2OH

HexCer 20:1;O2/15:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 20:1;O2/15:0;3OH

HexCer 20:1;O2/15:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 20:1;O2/15:0;O

HexCer 20:1;O2/15:0;O

C41H79NO9 (729.5754524)


   

HexCer 21:0;O2/15:0

HexCer 21:0;O2/15:0

C42H83NO8 (729.6118358)


   

HexCer 21:0;O3/14:1

HexCer 21:0;O3/14:1

C41H79NO9 (729.5754524)


   

HexCer 21:1;O2/14:0;2OH

HexCer 21:1;O2/14:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 21:1;O2/14:0;3OH

HexCer 21:1;O2/14:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 21:1;O2/14:0;O

HexCer 21:1;O2/14:0;O

C41H79NO9 (729.5754524)


   

HexCer 22:0;O2/14:0

HexCer 22:0;O2/14:0

C42H83NO8 (729.6118358)


   

HexCer 22:1;O2/13:0;2OH

HexCer 22:1;O2/13:0;2OH

C41H79NO9 (729.5754524)


   

HexCer 22:1;O2/13:0;3OH

HexCer 22:1;O2/13:0;3OH

C41H79NO9 (729.5754524)


   

HexCer 22:1;O2/13:0;O

HexCer 22:1;O2/13:0;O

C41H79NO9 (729.5754524)